S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
NASDAQ:CRSP

CRISPR Therapeutics Insider Trades

$79.90
+1.92 (+2.46%)
(As of 11/30/2021 04:00 PM ET)
Add
Compare
Today's Range
$76.81
$80.50
50-Day Range
$77.98
$121.25
52-Week Range
$76.71
$220.20
Volume
1.47 million shs
Average Volume
1.61 million shs
Market Capitalization
$6.11 billion
P/E Ratio
16.79
Dividend Yield
N/A
Beta
2.09

CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.70%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$90.89 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


CRISPR Therapeutics (NASDAQ CRSP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2021Michael John TomsicekCFOSell25,000$138.52$3,463,000.0026,891  
8/4/2021Samarth KulkarniCEOSell1,500$125.02$187,530.00189,219  
7/19/2021Bradley J Phd BolzonDirectorSell10,000$126.43$1,264,300.00  
6/30/2021Rodger NovakPresidentSell25,000$165.00$4,125,000.00573,007  
6/28/2021Bradley J. Phd BolzonDirectorSell20,375$152.48$3,106,780.0017,159  
6/21/2021Rodger NovakPresidentSell25,000$128.62$3,215,500.00646,836  
6/15/2021Samarth KulkarniCEOSell30,000$126.43$3,792,900.00217,719  
6/11/2021Bradley J Phd BolzonDirectorSell10,000$126.61$1,266,100.0024,948  
3/22/2021Bradley J Phd BolzonDirectorSell30,374$132.37$4,020,606.3857,149  
1/19/2021James R. KasingerGeneral CounselSell27,500$204.94$5,635,850.00  
1/15/2021Lawrence Otto KleinCOOSell25,000$215.20$5,380,000.0028,666  
1/15/2021Samarth KulkarniCEOSell20,000$213.67$4,273,400.00202,989  
12/21/2020Tony W. HoVPSell23,551$149.23$3,514,515.73  
12/16/2020Bradley J Phd BolzonDirectorSell7,648$148.95$1,139,169.606,734  
12/10/2020Bradley J Phd BolzonDirectorSell33,000$143.35$4,730,550.0040,648  
12/10/2020Samarth KulkarniCEOSell20,000$142.29$2,845,800.00189,189  
12/7/2020Bradley J Phd BolzonDirectorSell171,004$154.53$26,425,248.1240,648  
11/30/2020Rodger NovakPresidentSell100,000$125.00$12,500,000.00698,007  
9/18/2020Bradley J Phd BolzonDirectorSell3,035$86.87$263,650.457,391  
9/16/2020Bradley J Phd BolzonDirectorSell8,965$86.98$779,775.707,391  
9/14/2020Bradley J Phd BolzonDirectorSell1,155$84.89$98,047.957,391  
9/10/2020Bradley J Phd BolzonDirectorSell22,845$85.36$1,950,049.207,391  
9/1/2020Bradley J Phd BolzonDirectorSell60,000$92.51$5,550,600.00  
9/1/2020Michael John TomsicekCFOSell12,000$92.26$1,107,120.0012,410  
9/1/2020Rodger NovakPresidentSell25,000$92.62$2,315,500.00651,940  
7/7/2020Rodger NovakPresidentSell25,000$90.00$2,250,000.00653,593  
7/6/2020Bradley J Phd BolzonDirectorSell20,000$82.39$1,647,800.00  
6/24/2020Lawrence Otto KleinCOOSell65,088$75.93$4,942,131.8458,666  
6/23/2020Bradley J Phd BolzonDirectorSell20,000$73.93$1,478,600.00  
6/23/2020Rodger NovakPresidentSell50,000$75.00$3,750,000.00698,007  
6/23/2020Tony W HoVPSell7,158$75.04$537,136.3240,676  
6/1/2020Samarth KulkarniCEOSell17,275$64.68$1,117,347.00188,801  
5/20/2020Samarth KulkarniCEOSell10,693$65.28$698,039.04175,833  
5/19/2020Rodger NovakPresidentSell50,000$65.00$3,250,000.00798,007  
5/11/2020Lawrence Otto KleinCOOSell25,000$60.40$1,510,000.0045,000  
11/19/2019Pablo J CagnoniDirectorSell7,500$62.00$465,000.007,500  
11/19/2019Rodger NovakPresidentSell33,618$70.00$2,353,260.0033,618  
11/12/2019Pablo J CagnoniDirectorSell7,500$55.00$412,500.007,500  
10/30/2019Pablo J CagnoniDirectorSell7,500$52.00$390,000.007,500  
7/11/2019Lawrence Otto KleinInsiderSell20,000$50.02$1,000,400.0031,579  
7/10/2019Rodger NovakPresidentSell50,000$50.00$2,500,000.00848,007  
6/17/2019Samarth KulkarniCEOSell20,000$46.00$920,000.00185,801  
6/10/2019Rodger NovakPresidentSell50,000$45.00$2,250,000.00898,007  
4/29/2019Samarth KulkarniCEOSell20,000$42.03$840,600.00186,542  
3/4/2019Rodger NovakPresidentSell85,220$40.40$3,442,888.001,024,534  
3/1/2019Rodger NovakPresidentSell8,693$40.01$347,806.931,024,534  
2/25/2019Rodger NovakPresidentSell14,780$40.00$591,200.001,033,227  
1/8/2019Rodger NovakPresidentSell17,310$35.09$607,407.901,130,697  
12/27/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy40,198$24.93$1,002,136.14  
12/24/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy90,742$24.08$2,185,067.36  
12/21/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy22,742$22.58$513,514.36  
12/18/2018Kurt Von EmsterDirectorSell72,934$29.85$2,177,079.90  
7/5/2018Pablo J CagnoniDirectorSell7,500$62.00$465,000.005,816  
7/3/2018Pablo J CagnoniDirectorSell5,816$62.00$360,592.005,816  
6/5/2018Kurt Von EmsterDirectorSell920$12.51$11,509.2090,000  
6/1/2018Samarth KulkarniCEOSell15,000$69.36$1,040,400.00163,560  
5/17/2018Rodger NovakPresidentSell75,000$60.00$4,500,000.001,183,247  
5/14/2018Kurt Von EmsterDirectorSell650,000$54.39$35,353,500.005,629  
5/11/2018Kurt Von EmsterDirectorSell250,000$52.84$13,210,000.00  
5/8/2018Bradley J Phd BolzonDirectorSell128,950$50.39$6,497,790.5037,645  
4/30/2018Bradley J Phd BolzonDirectorSell30,566$50.29$1,537,164.1443,986  
4/27/2018Thomas WoiwodeDirectorSell222,258$50.11$11,137,348.38  
4/24/2018Versant Venture Capital V, L.PMajor ShareholderSell22,841$50.99$1,164,662.59  
4/23/2018Bradley J Phd BolzonDirectorSell101,994$50.68$5,169,055.9243,986  
1/16/2018Tyler Dylan-HydeInsiderSell66,000$28.03$1,849,980.0025,204  
1/5/2018Aktiengesellschaft BayerMajor ShareholderBuy527,472$22.75$11,999,988.00  
1/5/2018Kurt Von EmsterDirectorSell92,337$26.96$2,489,405.52  
1/2/2018Kurt Von EmsterDirectorSell37,754$26.76$1,010,297.04  
1/2/2018Tyler Dylan-HydeInsiderSell38,000$21.64$822,320.0070,204  
12/29/2017Tyler Dylan-HydeInsiderSell31,000$22.72$704,320.00  
12/28/2017Tyler Dylan-HydeInsiderSell700$21.75$15,225.00115,904  
12/22/2017Thomas WoiwodeDirectorSell3,059$20.29$62,067.114,959  
12/22/2017Tyler Dylan-HydeInsiderSell15,000$20.55$308,250.00115,204  
12/15/2017Tyler Dylan-HydeInsiderSell15,000$18.90$283,500.00130,204  
12/4/2017Corp /De/ CelgeneMajor ShareholderSell1,112,446$18.98$21,114,225.08  
12/1/2017Corp /De/ CelgeneMajor ShareholderSell87,991$19.10$1,680,628.10  
11/29/2017Corp /De/ CelgeneMajor ShareholderSell4,263$19.25$82,062.75  
11/27/2017Corp /De/ CelgeneMajor ShareholderSell27,990$19.75$552,802.50  
11/27/2017Thomas WoiwodeDirectorSell200$20.24$4,048.008,218  
11/24/2017Corp /De/ CelgeneMajor ShareholderSell26,010$20.00$520,200.00  
11/24/2017Thomas WoiwodeDirectorSell1,700$20.21$34,357.008,218  
11/22/2017Corp /De/ CelgeneMajor ShareholderSell256,000$19.76$5,058,560.00  
11/20/2017Corp /De/ CelgeneMajor ShareholderSell158,718$19.02$3,018,816.36  
11/17/2017Corp /De/ CelgeneMajor ShareholderSell51,282$18.44$945,640.08  
11/15/2017Corp /De/ CelgeneMajor ShareholderSell15,000$17.67$265,050.00  
11/13/2017Corp /De/ CelgeneMajor ShareholderSell65,093$17.76$1,156,051.68  
11/10/2017Corp /De/ CelgeneMajor ShareholderSell10,000$17.28$172,800.00  
11/8/2017Corp /De/ CelgeneMajor ShareholderSell16,875$18.06$304,762.50  
11/6/2017Corp /De/ CelgeneMajor ShareholderSell79,327$18.89$1,498,487.03  
11/3/2017Corp /De/ CelgeneMajor ShareholderSell22,759$19.10$434,696.90  
9/5/2017Rodger NovakCEOSell18,470$20.76$383,437.201,148,007  
8/30/2017Rodger NovakCEOSell75,795$20.25$1,534,848.751,232,697  
8/30/2017Samarth KulkarniInsiderSell27,154$20.08$545,252.32110,893  
8/28/2017Kurt Von EmsterDirectorSell88,011$19.79$1,741,737.69  
8/25/2017Kurt Von EmsterDirectorSell22,781$19.42$442,407.02  
8/23/2017Kurt Von EmsterDirectorSell17,989$18.53$333,336.17  
8/21/2017Kurt Von EmsterDirectorSell3,150$18.52$58,338.00  
8/17/2017Kurt Von EmsterDirectorSell34,141$19.06$650,727.46  
8/15/2017Kurt Von EmsterDirectorSell55,569$19.59$1,088,596.71  
8/8/2017Kurt Von EmsterDirectorSell35,473$18.63$660,861.99  
8/8/2017Tyler Dylan-HydeInsiderSell15,000$18.57$278,550.00167,727  
8/4/2017Kurt Von EmsterDirectorSell50,477$17.81$898,995.37  
8/1/2017Kurt Von EmsterDirectorSell5,512$17.51$96,515.12  
7/28/2017Kurt Von EmsterDirectorSell41,312$17.63$728,330.56  
7/26/2017Kurt Von EmsterDirectorSell32,930$17.60$579,568.00  
7/14/2017Kurt Von EmsterDirectorSell69,859$16.84$1,176,425.56  
7/12/2017Kurt Von EmsterDirectorSell31,992$16.56$529,787.52  
7/5/2017Kurt Von EmsterDirectorSell4,254$16.26$69,170.04  
6/29/2017Kurt Von EmsterDirectorSell43,202$16.90$730,113.80  
6/27/2017Kurt Von EmsterDirectorSell81,435$17.08$1,390,909.80  
6/23/2017Kurt Von EmsterDirectorSell32,368$16.23$525,332.64  
6/22/2017Rodger NovakCEOSell10,825$15.37$166,380.251,225,830  
6/21/2017Rodger NovakCEOSell30,222$15.01$453,632.221,230,397  
6/9/2017Rodger NovakCEOSell5,303$15.02$79,651.061,219,208  
5/30/2017Rodger NovakCEOSell3,650$15.02$54,823.001,218,655  
5/17/2017Rodger NovakCEOSell50,000$16.26$813,000.001,239,082  
5/5/2017Rodger NovakCEOSell616$16.92$10,422.721,215,621  
5/4/2017Rodger NovakCEOSell49,384$16.30$804,959.201,230,929  
4/28/2017Tyler Dylan-HydeInsiderSell21,639$16.78$363,102.42180,495  
4/27/2017Samarth KulkarniInsiderSell5,481$16.76$91,861.56137,322  
4/25/2017Samarth KulkarniInsiderSell11,615$16.78$194,899.70137,047  
4/20/2017Rodger NovakCEOSell50,000$17.88$894,000.001,262,711  
4/20/2017Tyler Dylan-HydeInsiderSell10,177$17.71$180,234.67200,274  
10/24/2016Corp /De/ CelgeneMajor ShareholderBuy800,150$14.00$11,202,100.00  
10/24/2016Simeon GeorgeDirectorBuy66,500$14.00$931,000.00  
(Data available from 1/1/2013 forward)












CRISPR Therapeutics (NASDAQ:CRSP) Insider Trade Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R. Kasinger, Kurt Von Emster, Lawrence Otto Klein, Michael John Tomsicek, Pablo J Cagnoni, Rodger Novak, Samarth Kulkarni, Tony W Ho, and Vertex Pharmaceuticals (Europe.Learn more on CRSP's insiders

What percentage of CRISPR Therapeutics stock is owned by insiders?

10.70% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings

Which CRISPR Therapeutics insiders have been selling company stock?

The following insiders have sold CRISPR Therapeutics stock in the last 24 months: Bradley J Phd Bolzon ($50,614,497.40), James R. Kasinger ($5,635,850.00), Lawrence Otto Klein ($11,832,131.84), Michael John Tomsicek ($4,570,120.00), Rodger Novak ($31,406,000.00), Samarth Kulkarni ($12,915,016.04), and Tony W Ho ($537,136.32).

How much insider selling is happening at CRISPR Therapeutics?

Insiders have sold a total of 1,028,166 CRISPR Therapeutics shares in the last 24 months for a total of $124,132,047.33 sold.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.